Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

CRL stock hub

Charles River Laboratories International, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CRLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.6B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

CRL

In the news

Latest news · CRL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.3

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-5.9

P25 -105.6P50 -46.5P75 -3.1

ROIC9.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CRL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

252

Groups with data

Currency

USD

Showing 252 of 252 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001100682
Company name	Charles River Laboratories International, Inc.
Country	United States
Country code	US
Cusip	159864107
Employees	19,700
Employees Change	-400%
Employees Change Percent	-1.99
Enterprise value	$11.4B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Diagnostics & Research
IPO Date	2000-06-23
Isin	US1598641074
Last refreshed	2026-05-10
Market cap	$8.6B
Market cap category	Mid-Cap
Price	$178
Price currency	USD
Rev Per Employee	204,418.48x
Sector	Healthcare
Sic	8731
Symbol	CRL
Website	https://www.criver.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.16%
EV Sales Forward	2.88x
EV/EBIT	21.88x
EV/EBITDA	12.85x
EV/FCF	29.21x
EV/Sales	2.84x
FCF yield	4.57%
Forward P/E	15.27x
P/B ratio	2.91x
P/S ratio	2.12x
PE Ratio10 Y	56.76x
PE Ratio5 Y	90.13x
PEG ratio	1.69x
PS Forward	2.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.97%
EBITDA Margin	22.09%
FCF margin	9.72%
Gross margin	34.46%
Gross Profit	$1.4B
Gross Profit Growth	-0.55%
Gross Profit Growth Q	-5.02%
Gross Profit Growth3 Y	-2.81%
Gross Profit Growth5 Y	4.11%
Net Income	$-184.7M
Net Income Growth Years	0%
Pretax Margin	-4.11%
Profit Margin	-4.59%
Profit Per Employee	$-9,373
ROA	4.26
Roa5y	5.15
ROCE	7.87
ROE	-5.87
Roe5y	9.05
ROIC	9.09
Roic5y	8.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.18%
Cagr15y	10.37%
Cagr1y	29.7%
Cagr20y	6.86%
Cagr3y	-2.43%
Cagr5y	-12.31%
EPS Growth Years	0
FCF Growth	-30.53%
FCF Growth3 Y	12.44%
FCF Growth5 Y	-3.98%
OCF Growth	-21.81%
OCF Growth Q	-76.08%
OCF Growth10 Y	6.59%
OCF Growth3 Y	-1.04%
OCF Growth5 Y	-1.3%
Revenue Growth	0.11x
Revenue Growth Q	1.19x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.53x
Revenue Growth5 Y	5.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.53
Assets	$7.7B
Cash	$191.8M
Current Assets	$1.5B
Current Liabilities	$1.1B
Debt	$3.1B
Debt EBITDA	$3.06
Debt Equity	$1.03
Debt FCF	$7.83
Equity	$3B
Interest Coverage	4.93
Liabilities	$4.7B
Long Term Assets	$6.2B
Long Term Liabilities	$3.6B
Net Cash	$-2.9B
Net Cash By Market Cap	$-33.58
Net Debt EBITDA	$3.23
Net Debt Equity	$0.96
Net Debt FCF	$7.34
Tangible Book Value	$-348.4M
Tangible Book Value Per Share	$-7.23
WACC	9.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.36
Inventory Turnover	8.12
Net Working Capital	$211.6M
Quick ratio	0.82
Working Capital	$395.1M
Working Capital Turnover	$9.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.02%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	119.58%
1Y total return	29.68%
200-day SMA	176.5
3Y total return	-7.13%
50-day SMA	170.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-48.15%
All Time High	460.2
All Time High Change	-61.4%
All Time High Date	2021-09-24
All Time Low	17.19
All Time Low Change	933.4%
All Time Low Date	2000-12-11
ATR	8.18
Beta	1.45
Beta1y	1.43
Beta2y	0.76
Ch YTD	-10.96
High	183.7
High52	228.9
High52 Date	2026-01-13
High52ch	-22.4%
Low	174.1
Low52	132.6
Low52 Date	2025-06-02
Low52ch	33.97%
Ma50ch	4.06%
Premarket Change Percent	-0.04
Premarket Price	$182
Premarket Volume	15,442
Price vs 200-day SMA	0.64%
RSI	53.11
RSI Monthly	48.41
RSI Weekly	50.5
Sharpe ratio	0.73x
Sortino ratio	1.16
Total Return	4.02%
Tr YTD	-10.96
Tr15y	339.44%
Tr1m	4.77%
Tr1w	7.14%
Tr3m	-6.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	3
Analyst Price Target Top	$185
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$1.95
Earnings EPS Estimate Growth	-16.67
Earnings Revenue Estimate	976,164,136x
Earnings Revenue Estimate Growth	-0.81x
Operating Income	$522.3M
Operating Income Growth	-1.41
Operating Income Growth Q	18.33
Operating Income Growth3 Y	-8.54
Operating Income Growth5 Y	1.11
Operating margin	12.97
Price target	$201
Price Target Change	$13.16
Price Target Change Top	$4.16

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47,601,904%
Float Percent	98.83%
Net Borrowing	168,056,000
Shares Insiders	1.08%
Shares Institutions	114.33%
Shares Out	48,167,730
Shares Qo Q	-0.54%
Shares Yo Y	-4.02%
Short Float	9.8%
Short Ratio	5.43
Short Shares	9.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$311M
Average Volume	814,617.25x
Bv Per Share	61.05
CAPEX	$-215.7M
Ch10y	119.6
Ch15y	339.4
Ch1m	4.77
Ch1w	7.14
Ch1y	29.68
Ch20y	276.9
Ch3m	-6.13
Ch3y	-7.13
Ch5y	-48.15
Ch6m	5.7
Change	-2.23%
Change From Open	-2.71
Close	181.7
Days Gap	0.48
Depreciation Amortization	367,299,000
Dollar Volume	173,746,818.3
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$522.3M
EBITDA	$889.6M
EPS	$-3.76
F Score	4
FCF	$391.3M
FCF EV Yield	3.42x
FCF Per Share	$8.12
Financing CF	-83,677,000
Fiscal Year End	December
Founded	1,947
Goodwill	3,040,032,000
Income Tax	$17.4M
Investing CF	-571,687,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-28
Last Split Type	Never
Last10k Filing Date	2026-02-18
Ma150	182.1
Ma150ch	-2.44%
Ma20	176.2
Ma20ch	0.82%
Net CF	-33,527,000
Next Earnings Date	2026-08-05
Open	182.6
Optionable	Yes
P FCF Ratio	21.86
P OCF Ratio	14.09
Position In Range	37.06
Post Close	177.6
Postmarket Change Percent	-0.77
Postmarket Price	$176
Ppne	1,827,994,000
Pre Close	181.7
Price Date	2026-05-08
Price EBITDA	$9.62
Relative Volume	1.2x
Revenue	4,027,044,000x
SBC By Revenue	1.99x
Share Based Comp	80,329,000
Tax By Revenue	0.43x
Tr20y	276.87%
Tr6m	5.7%
Us State	Massachusetts
Volume	978,194
Z Score	2.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CRL pay a dividend?

Capital-return profile for this ticker.

Performance

CRL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CRL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+114.3%

Float: +98.8% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CRL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.1

Neutral momentum band

Price vs 200-day MA

+0.6%

50/200-day relationship not available

Beta (5Y)

1.45

More volatile than the market

Sharpe ratio

0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CRL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CRL stock rating?

Charles River Laboratories International, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CRL analysis?

The full report lives at /stocks/CRL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CRL?

The latest report frames CRL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CRL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.